Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Seminars in Oncology|February 1, 1995
Induction chemotherapy with ifosfamide, etoposide, and anthracycline for small cell lung cancer: experience of the European Lung Cancer Working PartyJ P Sculier, G Bureau, V Giner, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 1998
Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the European Lung Cancer Working PartyM Paesmans, J P Sculier, P Libert, et al.
International Journal of Oncology|May 10, 2011
A phase-ii study testing a combination chemotherapy with epirubicin and vindesine as 2nd line treatment for patients with advanced non-small-cell lung-cancerJ Sculier, G Bureau, J Thiriaux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
A phase II randomised trial comparing the cisplatin-etoposide combination chemotherapy with or without carboplatin as second-line therapy for small-cell lung cancerJ P Sculier, J J Lafitte, J Lecomte, et al.
Cancer|August 10, 2000
Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 yearsM Paesmans, J P Sculier, J Lecomte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working PartyJ P Sculier, M Paesmans, G Bureau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancerJ P Sculier, J J Lafitte, J Lecomte, et al.
Lung Cancer (Amsterdam, Netherlands)|December 1, 1996
Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer. (NSCLC)M Borges, J P Sculier, M Paesmans, et al.
Revue Des Maladies Respiratoires|March 13, 1998
[Prognostic factors in advanced stage non-small cell bronchial cancer: experiences of the European Lung Cancer Working Party]J P Sculier, M Paesmans, P Libert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working PartyJ P Sculier, M Paesmans, J Thiriaux, et al.
Pageof 3